<?xml version="1.0" encoding="UTF-8"?>
<p id="p0175">It is of utmost importance to promote the design of prospective clinical trials to test the hypothesis: â€˜Does a post-exposure non-toxic dose of hydroxychloroquine significantly alter SARS-CoV-2 replication in people exposed to a documented infective contact; and does it reduce the severity of subsequent disease? These futures clinical trials should document the benefit/risk ratio of this strategy rapidly.</p>
